메뉴 건너뛰기




Volumn 95, Issue 4, 2013, Pages 235-240

Novel xylan-controlled delivery of therapeutic proteins to inflamed colon by the human anaerobic commensal bacterium

Author keywords

Bacteroides ovatus; Inflammatory bowel disease; Xylan

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXTRAN SULFATE; FIBROBLAST GROWTH FACTOR 10; IRRITANT AGENT; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; XYLAN;

EID: 84877834249     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588413X13511609958217     Document Type: Article
Times cited : (15)

References (23)
  • 1
    • 2442563304 scopus 로고    scopus 로고
    • Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
    • Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1,504-1,517.
    • (2004) Gastroenterology , vol.126 , pp. 1504-1517
    • Loftus, E.V.1
  • 2
    • 4143069158 scopus 로고    scopus 로고
    • High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease
    • Darfeuille-Michaud A, Boudeau J, Bulois P et al. High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421.
    • (2004) Gastroenterology , vol.127 , pp. 412-421
    • Darfeuille-Michaud, A.1    Boudeau, J.2    Bulois, P.3
  • 3
    • 33745413808 scopus 로고    scopus 로고
    • Probiotics and inflammatory bowel diseases
    • Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases. Postgrad Med J 2006; 82: 376-382.
    • (2006) Postgrad Med J , vol.82 , pp. 376-382
    • Bai, A.P.1    Ouyang, Q.2
  • 4
    • 0031815046 scopus 로고    scopus 로고
    • Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine
    • Steidler L, Robinson K, Chamberlain L et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 1998; 66: 3,183-3,189.
    • (1998) Infect Immun , vol.66 , pp. 3183-3189
    • Steidler, L.1    Robinson, K.2    Chamberlain, L.3
  • 5
    • 0034556237 scopus 로고    scopus 로고
    • Secretion of biologically active murine interleukin-10 by Lactococcus lactis
    • Schotte L, Steidler L, Vandekerckhove J, Remaut E. Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microb Technol 2000; 27: 761-765.
    • (2000) Enzyme Microb Technol , vol.27 , pp. 761-765
    • Schotte, L.1    Steidler, L.2    Vandekerckhove, J.3    Remaut, E.4
  • 6
    • 0034714188 scopus 로고    scopus 로고
    • Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
    • Steidler L, Hans W, Schotte L et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1,352-1,355.
    • (2000) Science , vol.289 , pp. 1352-1355
    • Steidler, L.1    Hans, W.2    Schotte, L.3
  • 7
    • 33744933432 scopus 로고    scopus 로고
    • A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease
    • Braat H, Rottiers P, Hommes DW et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 754-759.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 754-759
    • Braat, H.1    Rottiers, P.2    Hommes, D.W.3
  • 8
    • 0037820426 scopus 로고    scopus 로고
    • Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
    • Steidler L, Neirynck S, Huyghebaert N et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003; 21: 785-789.
    • (2003) Nat Biotechnol , vol.21 , pp. 785-789
    • Steidler, L.1    Neirynck, S.2    Huyghebaert, N.3
  • 9
    • 40049097099 scopus 로고    scopus 로고
    • Epithelial restitution and wound healing in inflammatory bowel disease
    • Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 2008; 14: 348-353.
    • (2008) World J Gastroenterol , vol.14 , pp. 348-353
    • Sturm, A.1    Dignass, A.U.2
  • 10
    • 17644378995 scopus 로고    scopus 로고
    • Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan
    • Farrar MD, Whitehead TR, Lan J et al. Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan. J Appl Microbiol 2005; 98: 1,191-1,197.
    • (2005) J Appl Microbiol , vol.98 , pp. 1191-1197
    • Farrar, M.D.1    Whitehead, T.R.2    Lan, J.3
  • 11
    • 55549088221 scopus 로고    scopus 로고
    • Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins
    • Hamady ZZ, Farrar M, Whitehead TR et al. Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology 2008; 154: 3,165-3,174.
    • (2008) Microbiology , vol.154 , pp. 3165-3174
    • Hamady, Z.Z.1    Farrar, M.2    Whitehead, T.R.3
  • 12
    • 77950799444 scopus 로고    scopus 로고
    • Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus
    • Hamady ZZ, Scott N, Farrar MD et al. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 2010; 59: 461-469.
    • (2010) Gut , vol.59 , pp. 461-469
    • Hamady, Z.Z.1    Scott, N.2    Farrar, M.D.3
  • 13
    • 80051504591 scopus 로고    scopus 로고
    • Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1
    • Hamady ZZ, Scott N, Farrar MD et al. Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1. Inflamm Bowel Dis 2011; 17: 1,925-1,935.
    • (2011) Inflamm Bowel Dis , vol.17 , pp. 1925-1935
    • Hamady, Z.Z.1    Scott, N.2    Farrar, M.D.3
  • 14
    • 0020681426 scopus 로고
    • Bacterial populations associated with different regions of the human colon wall
    • Croucher SC, Houston AP, Bayliss CE, Turner RJ. Bacterial populations associated with different regions of the human colon wall. Appl Environ Microbiol 1983; 45: 1,025-1,033.
    • (1983) Appl Environ Microbiol , vol.45 , pp. 1025-1033
    • Croucher, S.C.1    Houston, A.P.2    Bayliss, C.E.3    Turner, R.J.4
  • 15
    • 0019445483 scopus 로고
    • Utilization of xylan by two species of human colonic Bacteroides
    • Salyers AA, Gherardini F, O'Brien M. Utilization of xylan by two species of human colonic Bacteroides. Appl Environ Microbiol 1981; 41: 1,065-1,068.
    • (1981) Appl Environ Microbiol , vol.41 , pp. 1065-1068
    • Salyers, A.A.1    Gherardini, F.2    O'Brien, M.3
  • 16
    • 0025273798 scopus 로고
    • The genes for three xylan-degrading activities from Bacteroides ovatus are clustered in a 3.8-kilobase region
    • Whitehead TR, Hespell RB. The genes for three xylan-degrading activities from Bacteroides ovatus are clustered in a 3.8-kilobase region. J Bacteriol 1990; 172: 2,408-2,412.
    • (1990) J Bacteriol , vol.172 , pp. 2408-2412
    • Whitehead, T.R.1    Hespell, R.B.2
  • 18
    • 2642532099 scopus 로고    scopus 로고
    • Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells
    • Visco V, Belleudi F, Marchese C et al. Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 2004; 200: 31-44.
    • (2004) J Cell Physiol , vol.200 , pp. 31-44
    • Visco, V.1    Belleudi, F.2    Marchese, C.3
  • 19
    • 2542473235 scopus 로고    scopus 로고
    • Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells
    • Murphy SJ, Doré JJ, Edens M et al. Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells. Mol Biol Cell 2004; 15: 2,853-2,862.
    • (2004) Mol Biol Cell , vol.15 , pp. 2853-2862
    • Murphy, S.J.1    Doré, J.J.2    Edens, M.3
  • 20
    • 0029995799 scopus 로고    scopus 로고
    • Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
    • Neurath MF, Fuss I, Kelsall BL et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996; 183: 2,605-2,616.
    • (1996) J Exp Med , vol.183 , pp. 2605-2616
    • Neurath, M.F.1    Fuss, I.2    Kelsall, B.L.3
  • 21
    • 0033673940 scopus 로고    scopus 로고
    • Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats
    • Han DS, Li F, Holt L et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1011-G1022.
    • (2000) Am J Physiol Gastrointest Liver Physiol , vol.279
    • Han, D.S.1    Li, F.2    Holt, L.3
  • 22
    • 0035895767 scopus 로고    scopus 로고
    • Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards
    • Epstein SE, Fuchs S, Zhou YF et al. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 2001; 49: 532-542.
    • (2001) Cardiovasc Res , vol.49 , pp. 532-542
    • Epstein, S.E.1    Fuchs, S.2    Zhou, Y.F.3
  • 23
    • 0025632985 scopus 로고
    • Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution
    • Wakefield LM, Winokur TS, Hollands RS et al. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990; 86: 1,976-1,984.
    • (1990) J Clin Invest , vol.86 , pp. 1976-1984
    • Wakefield, L.M.1    Winokur, T.S.2    Hollands, R.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.